Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.73 CAD | +0.70% | +0.17% | +10.40% |
Mar. 22 | Knight Therapeutics Price Target Raised to $7 at RBC | MT |
Mar. 21 | Knight Therapeutics Reports Fourth Quarter Results | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.40% | 420M | |
+5.31% | 69.91B | |
+10.97% | 9.03B | |
-16.83% | 4.75B | |
+43.48% | 4.31B | |
+3.20% | 3.88B | |
+18.82% | 2.37B | |
-21.36% | 2.26B | |
-29.67% | 2.2B | |
+8.38% | 1.98B |
- Stock Market
- Equities
- GUD Stock
- News Knight Therapeutics Inc.
- Knight Therapeutics : Announces Canadian Commercial Launch of New Treatment for Irritable Bowel Syndrome